structure of the parental antibody and substitution of the crystallizable fragment (Fc) region with a monovalent variable fragment (Fv) to secure an additional binding arm. The resulting ALiCE ...

Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...